These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7102023)
1. [Correlation between psoriasis and cardiovascular diseases (author's transl)]. Török L; Tóth E; Bruncsák A Z Hautkr; 1982 May; 57(10):734-9. PubMed ID: 7102023 [TBL] [Abstract][Full Text] [Related]
2. [Effect of angina in the week before myocardial infarction on long-term cardiovascular morbidity and mortality after hospital discharge]. Jiménez-Navarro MF; Gómez-Doblas JJ; Ramírez-Marrero MA; García-Alcántara A; Cabrera-Bueno F; Alonso-Briales JH; Salva D; de Teresa Galván E Rev Esp Cardiol; 2008 Jul; 61(7):775-8. PubMed ID: 18590652 [TBL] [Abstract][Full Text] [Related]
3. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Kaye JA; Li L; Jick SS Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778 [TBL] [Abstract][Full Text] [Related]
4. [Sudden cardiac death. Identification and treatment of candidates for sudden cardiac death. 1. Statistics, symptoms, pathology, pathogenesis]. Michel D Fortschr Med; 1978 Feb; 96(8):374-9. PubMed ID: 631719 [No Abstract] [Full Text] [Related]
5. Research in practice: the systemic aspects of psoriasis. Boehncke WH; Boehncke S J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207 [TBL] [Abstract][Full Text] [Related]
6. [One-year follow-up of a population of patients with angina. Factors influencing mortality and occurrence of cardiovascular events. Results of the ELAN study]. Guize L; Ducimetière P; Consoli SM; Kolsky H; Raynaud P; Walch JM; Paul-Dauphin A; Duprat-Lomon I Arch Mal Coeur Vaiss; 2000 Mar; 93(3):227-37. PubMed ID: 11004968 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis: cardiovascular risk factors and other disease comorbidities. Wu Y; Mills D; Bala M J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519 [TBL] [Abstract][Full Text] [Related]
8. Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease. Yalcin H; Balci DD; Ucar E; Ozcelik N; Tasci C; Seyfeli E; Akgul F; Yalcin F J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):798-802. PubMed ID: 19470047 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the adhesive capacity of thrombocytes in patients with afflictions of the circulatory system (author's transl)]. Köstering H; Walther C; Grüne M; König F; Völker P Z Klin Chem Klin Biochem; 1973 May; 11(5):215-9. PubMed ID: 4804175 [No Abstract] [Full Text] [Related]
17. Psoriasis and cardiovascular disease. Vena GA; Vestita M; Cassano N Dermatol Ther; 2010; 23(2):144-51. PubMed ID: 20415821 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164 [TBL] [Abstract][Full Text] [Related]
19. [Our experience of psoriatic arthritis and psoriasis treatment with methotrexate (author's transl)]. Zbojanová M; Vlcek F; Trnavský K Cesk Dermatol; 1980 Feb; 55(1):39-44. PubMed ID: 6988086 [No Abstract] [Full Text] [Related]
20. [Patients with psoriasis have an increased risk of cardiovascular diseases]. Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]